India’s Granules will do a significant expansion of its API bulk drug site in Vishakhapatnam, and is getting substantial help from the International Finance…

Charles River Laboratories has unloaded QS Pharma, a Philadelphia-area CDMO, months after picking it up as part of its $585 million buyout of WIL Research.

France-based IBA Molecular has picked up two manufacturing sites, including one in the U.S., as part of its $690 million deal to buy the nuclear medicines…

Sun Pharma is said to be shopping its Ohm Laboratories plants in New Jersey as part of a manufacturing consolidation.

France’s Ipsen will get a manufacturing foothold in the U.S. with a new deal to expand its oncology reach in the country.

India’s Aurobindo Pharma, which has been building its presence around the world, has struck a new deal to buy a generics manufacturer and plant in Portugal…

Swiss CMO Lonza, which has been searching for a game-changing M&A deal, looks to have unearthed one in contractor Capsugel.

Sanofi recently that it will sell off its generic drug unit in Europe, a decision that will affect two manufacturing plants in the Czech Republic and Romania.

M&A